On Monday, Punjab based IOL Chemicals and Pharmaceuticals said that it has got approval from the US health regulator USFDA for its Ibuprofen manufacturing facility in Barnala, Punjab.

In a BSE filing, IOLCP said, the company has received establishment inspection report from the US Food and Drug Administration (USFDA) for the Barnala-based facility.

“Post this approval, IOLCP will be able to garner additional business for its flagship Iburofen in world’s largest pharma market–USA,” it added.

Get profitable free intraday tips